# GMFB

## Overview
The GMFB gene encodes the protein glia maturation factor beta, which is predominantly expressed in the central nervous system. This protein is classified as an intracellular signaling molecule, with roles extending to both intracellular and extracellular environments. GMFB is integral to the regulation of actin dynamics, influencing cell shape, motility, and differentiation, which are essential processes in neurodevelopment and neuroprotection (Fan2018Glia). It activates key signaling pathways, such as p38 MAP kinase and NF-kB, which are involved in inflammatory responses and neurotrophic interactions (Zaheer2006A). GMFB's interactions with neurotrophins like NGF and BDNF further underscore its role in neuroprotection and neurogenesis (Fan2018Glia). Additionally, GMFB has been implicated in various pathological conditions, including neurodegenerative diseases and certain cancers, highlighting its potential as a therapeutic target (Zhu2022Glia; Zaheer2008Glia).

## Function
Glia maturation factor beta (GMFB) is a protein primarily expressed in the central nervous system, where it plays a crucial role in various cellular processes. GMFB is involved in the regulation of actin dynamics, which influences cell shape and motility, essential for cell migration and differentiation (Fan2018Glia). It is an intracellular protein that can also be secreted under certain conditions, acting as a signaling molecule both intracellularly and extracellularly (Fan2018Glia).

In astrocytes, GMFB activates signaling pathways such as p38 MAP kinase and NF-kB, which are important for the induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) and pro-inflammatory cytokines (Zaheer2006A). This activation is crucial for modulating inflammatory responses in the central nervous system (Zaheer2006A). GMFB also interacts with neurotrophins like nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), enhancing their expression and contributing to neuroprotection (Fan2018Glia).

GMFB's role extends to neurodevelopment, where it is involved in the regulation of cell differentiation and proliferation. It is expressed in various glial cells and neurons, indicating its importance in neurogenesis and the development of the nervous system (Fan2018Glia).

## Clinical Significance
Glia maturation factor beta (GMFB) has been implicated in several diseases due to alterations in its expression levels and interactions. In kidney renal clear cell carcinoma (KIRC), GMFB is identified as a prognostic biomarker. Higher expression levels of GMFB are associated with better overall survival and disease-free survival, suggesting its role as a tumor suppressor. GMFB overexpression in KIRC cells leads to decreased cell viability and proliferation, while knockdown results in increased cell viability, indicating its potential as a therapeutic target (Zhu2022Glia).

In the context of neurodegenerative diseases, GMFB is involved in the production of pro-inflammatory cytokines. Its overexpression in astrocytes can lead to increased susceptibility to oxidative stress and cytotoxicity, contributing to conditions like multiple sclerosis (Zaheer2006A). GMFB is also linked to Alzheimer's disease, where it modulates glial activation and inflammatory cytokine production, exacerbating neuronal damage (Zaheer2008Glia).

In diabetic osteoporosis, GMFB deficiency has been shown to protect against osteoclast hyperactivity, suggesting its role in bone resorption processes. GMFB interacts with the Arp2/3 complex, affecting actin dynamics and osteoclast function, making it a potential target for therapeutic intervention in bone-related diseases (Shi2023Glia).

## Interactions
Glia Maturation Factor Beta (GMFB) is involved in several protein interactions that influence its role in neuroinflammation and neuroprotection. GMFB interacts with the actin-related protein 2/3 (Arp2/3) complex, acting as a debranching factor that modulates actin dynamics by inhibiting the complex's function. This interaction is crucial for the formation and dynamics of the sealing zone in osteoclasts (Shi2023Glia). GMFB is also methylated by the enzyme G9a at lysine residues K20 and K25, a modification linked to neurodegeneration. Inhibition of G9a reduces GMFB methylation, suggesting that G9a is the methyltransferase responsible for this modification (BellverSanchis2024G9a). 

GMFB is phosphorylated by protein kinase A (PKA), which enhances p38 MAPK activity and inhibits ERK1/ERK2, influencing the secretion of pro-inflammatory cytokines (Fan2018Glia). GMFB also interacts with the NF-κB signaling pathway, where its overexpression leads to increased NF-κB activity, resulting in the secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) (Fan2018Glia). These interactions highlight GMFB's role in modulating signaling pathways that are critical in neuroinflammatory and neurodegenerative processes.


## References


[1. (Zaheer2008Glia) Asgar Zaheer, Smita Zaheer, Ramasamy Thangavel, Yanghong Wu, Shailendra K. Sahu, and Baoli Yang. Glia maturation factor modulates β-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage. Brain Research, 1208:192–203, May 2008. URL: http://dx.doi.org/10.1016/j.brainres.2008.02.093, doi:10.1016/j.brainres.2008.02.093. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.brainres.2008.02.093)

[2. (Zhu2022Glia) Tong Zhu, Tianyu Wang, Zijun Feng, Furong Gao, Jieping Zhang, Caixia Jin, Haibin Tian, Jingying Xu, Hao Chen, Qingjian Ou, Juan Wang, Guotong Xu, and Lixia Lu. Glia maturation factor β as a novel independent prognostic biomarker and potential therapeutic target of kidney renal clear cell carcinoma. Frontiers in Oncology, July 2022. URL: http://dx.doi.org/10.3389/fonc.2022.880100, doi:10.3389/fonc.2022.880100. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.880100)

[3. (BellverSanchis2024G9a) Aina Bellver-Sanchis, Qizhi Geng, Gemma Navarro, Pedro A. Ávila-López, Júlia Companys-Alemany, Laura Marsal-García, Raquel Larramona-Arcas, Lluisa Miró, Anna Perez-Bosque, Daniel Ortuño-Sahagún, Deb Ranjan Banerjee, Bhanwar Singh Choudhary, Francesc X Soriano, Coralie Poulard, Mercè Pallàs, Hai-Ning Du, and Christian Griñán-Ferré. G9a inhibition promotes neuroprotection through gmfb regulation in alzheimer’s disease. Aging and disease, 15(1):311, 2024. URL: http://dx.doi.org/10.14336/AD.2023.0424-2, doi:10.14336/ad.2023.0424-2. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.14336/AD.2023.0424-2)

[4. (Zaheer2006A) Asgar Zaheer, Smita Zaheer, Shailendra K. Sahu, Scott Knight, Houdy Khosravi, Satya N. Mathur, and Ramon Lim. A novel role of glia maturation factor: induction of granulocyte‐macrophage colony‐stimulating factor and pro‐inflammatory cytokines. Journal of Neurochemistry, 101(2):364–376, November 2006. URL: http://dx.doi.org/10.1111/j.1471-4159.2006.04385.x, doi:10.1111/j.1471-4159.2006.04385.x. This article has 73 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1471-4159.2006.04385.x)

[5. (Fan2018Glia) Junsheng Fan, Tszhei Fong, Xinjie Chen, Chuyun Chen, Peng Luo, and Haiting Xie. Glia maturation factor-&amp;beta;: a potential therapeutic target in neurodegeneration and neuroinflammation. Neuropsychiatric Disease and Treatment, Volume 14:495–504, February 2018. URL: http://dx.doi.org/10.2147/NDT.S157099, doi:10.2147/ndt.s157099. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.2147/NDT.S157099)

[6. (Shi2023Glia) Si Shi, Huijie Gu, Jinyuan Xu, Wan Sun, Caiyin Liu, Tong Zhu, Juan Wang, Furong Gao, Jieping Zhang, Qingjian Ou, Caixia Jin, Jingying Xu, Hao Chen, Jiao Li, Guotong Xu, Haibin Tian, and Lixia Lu. Glia maturation factor beta deficiency protects against diabetic osteoporosis by suppressing osteoclast hyperactivity. Experimental &amp; Molecular Medicine, 55(5):898–909, May 2023. URL: http://dx.doi.org/10.1038/s12276-023-00980-8, doi:10.1038/s12276-023-00980-8. This article has 1 citations.](https://doi.org/10.1038/s12276-023-00980-8)